The Family Firm’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,797
| Closed | -$551K | – | 206 |
|
|
2025
Q1 | $551K | Hold |
6,797
| – | – | 0.12% | 108 |
|
|
2024
Q4 | $612K | Buy |
6,797
+243
| +4% | +$21.9K | 0.14% | 101 |
|
|
2024
Q3 | $648K | Buy |
6,554
+1
| +0% | +$99 | 0.14% | 102 |
|
|
2024
Q2 | $608K | Buy |
6,553
+8
| +0.1% | +$742 | 0.14% | 100 |
|
|
2024
Q1 | $621K | Sell |
6,545
-217
| -3% | -$20.6K | 0.15% | 96 |
|
|
2023
Q4 | $604K | Buy |
6,762
+182
| +3% | +$16.3K | 0.16% | 93 |
|
|
2023
Q3 | $480K | Buy |
6,580
+824
| +14% | +$60.2K | 0.13% | 102 |
|
|
2023
Q2 | $479K | Buy |
5,756
+841
| +17% | +$70K | 0.13% | 104 |
|
|
2023
Q1 | $375K | Sell |
4,915
-119
| -2% | -$9.07K | 0.1% | 120 |
|
|
2022
Q4 | $418K | Buy |
5,034
+482
| +11% | +$40K | 0.12% | 110 |
|
|
2022
Q3 | $361K | Hold |
4,552
| – | – | 0.12% | 115 |
|
|
2022
Q2 | $338K | Buy |
+4,552
| New | +$338K | 0.1% | 132 |
|